n!Biomachines Partners with Weizmann Institute of Science to Validate and Advance Bioreactor Technology

BURLINGTON, CANADA, November 3, 2025 – n!Biomachines Ltd., a subsidiary of The Cultivated B GmbH, and the Weizmann Institute of Science have entered a Memorandum of Understanding (MOU) to validate and advance the functionality of n!Biomachines’ next-generation bioreactor systems.

Through this collaboration, the Weizmann Institute – one of the world’s most respected centers of scientific research – will rigorously test n!Biomachines’ bioreactor technology under a variety of experimental conditions. The partnership is designed to generate meaningful insights into bioreactor performance, support the joint publication of white papers and scientific articles, and create reference points for broader academic and industrial use. By leveraging the Weizmann Institute’s expertise in life sciences and its reputation for excellence, n!Biomachines strengthens the scientific foundation and trustworthiness of its bioproduction technology.

“Our collaboration with the Weizmann Institute represents a major step in validating and evolving our bioreactor technology,” said Dr. Hamid Noori, CEO of The Cultivated B and its subsidiary n!Biomachines. “Working alongside one of the most respected scientific institutions worldwide ensures that our technology is tested at the highest standards, helping us to refine performance and bring robust, scalable solutions to the field of biomanufacturing.”

The collaboration reflects the Institute’s commitment to partnering with leading innovators in bioreactor design and biomanufacturing. The combined expertise of Weizmann’s research teams and n!Biomachines’ engineering capabilities is expected to create powerful synergies that drive advancements in bioprocessing and sustainable bioproduction.

By integrating academic rigor with industrial innovation, the partnership between n!Biomachines and the Weizmann Institute of Science demonstrates the critical role of validation and collaboration in shaping the future of sustainable bioproduction.

About n!Biomachines

n!Biomachines, a subsidiary of The Cultivated B, specializes in developing and manufacturing fit-for-purpose bioreactors for the next generation of bioprocessing. It targets benchtop, pilot- and industrial-scale bioprocessing, ensuring high-quality, safe and efficient operations. Unlike traditional bioreactors that were designed primarily for the pharmaceutical industry, n!Biomachines provides affordable, user-friendly systems for various bioprocesses and organisms, improving commercial viability and scalability for the food, supplement and cosmetics industries. By overcoming industry growth barriers, n!Biomachines aims to revolutionize manufacturing and facilitate the adoption of cellular agriculture technologies sustainably and efficiently. For more information, visit https://www.n-factorial.com/ and follow the company on LinkedIn.

Cultivated B Logo

About The Cultivated B

The Cultivated B (TCB) is driving the transformation of food and food ingredient manufacturing towards a sustainable future. By developing specialized bioreactors and fermenters while applying innovative technologies such as precision fermentation and molecular farming, TCB accelerates the commercialization of alternative proteins economically and at scale. TCB’s comprehensive portfolio of products and services is tailored to the needs of innovative food, supplements, and advanced materials companies. TCB works with companies to embed these sustainable technologies on local, regional and global scales, with operations in Europe and North America and a robust network of strategic partners in the Middle East, East Asia and Latin America. For more information, visit www.thecultivatedb.com and follow the company on LinkedIn.